Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
Research and development spending
3Y CAGR
+18.6%/yr
vs +91.0%/yr prior
5Y CAGR
+31.2%/yr
Recent deceleration
Acceleration
-72.4pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
3.9x
Strong expansion
Streak
3 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $148.02M | +1.8% |
| 2024 | $145.40M | +9.5% |
| 2023 | $132.84M | +49.5% |
| 2022 | $88.84M | -46.9% |
| 2021 | $167.21M | +339.7% |
| 2020 | $38.02M | +273.9% |
| 2019 | $10.17M | +52.4% |
| 2018 | $6.67M | - |